RXO (RXO) Misses Q2 EPS by 17c, provides outlook

RXO (NYSE: RXO) reported Q2 EPS of ($0.06), $0.17 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $930 billion versus the consensus estimate of $1 billion.

Third-Quarter Outlook

RXO expects third-quarter 2024 companywide adjusted EBITDA to be between $28 million and $34 million. The company expects third-quarter 2024 Brokerage gross margin to be between 13% and 15%.

For earnings history and earnings-related data on RXO (RXO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c